Modulation of endoplasmic reticulum calcium pump expression during lung cancer cell differentiation

FEBS Journal

Volumn 280, Issue 21, 2013, Pages 5408-5418

  Arbabian, Atousa ^a,b   Brouland, Jean Philippe ^c   Apáti, Ágota ^d,e   Pászty, Katalin ^f   Hegedus, Luca ^d   Enyedi, Ágnes ^d,e   Chomienne, Christine ^a,b   Papp, Béla ^a,b,g  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^e National Blood Service   (Hungary)

^f SEMMELWEIS UNIVERSITY   (Hungary)

^g UNIVERSITÉ PARIS 13   (France)

Author keywords

calcium; differentiation; endoplasmic reticulum; lung cancer; SERCA

Indexed keywords

CALCIUM; PROTEIN SERCA2; PROTEIN SERCA3; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

BRONCHUS MUCOSA; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CARCINOMA CELL; CELL DAMAGE; CELL DIFFERENTIATION; CELL FUNCTION; CONFERENCE PAPER; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CALCIUM; DIFFERENTIATION; ENDOPLASMIC RETICULUM; LUNG CANCER; SERCA;

ADENOCARCINOMA; BLOTTING, WESTERN; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOPLASMIC RETICULUM; HOMEOSTASIS; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 84886101632     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12064     Document Type: Conference Paper

References (60)

1. Travis WD, (2004) World Health Organization, International Agency for Research on Cancer, International Association for the Study of Lung Cancer, International Academy of Pathology: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus, and Heart. IARC Press, Lyon.
2. Youlden DR, Cramb SM, &, Baade PD, (2008) The international epidemiology of lung cancer: geographical distribution and secular trends. J Thorac Oncol 3, 819-831.
3. Berridge MJ, (2009) Inositol trisphosphate and calcium signalling mechanisms. Biochim Biophys Acta 1793, 933-940.
4. Berridge MJ, (2002) The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium 32, 235-249.
5. Coe H, &, Michalak M, (2009) Calcium binding chaperones of the endoplasmic reticulum. Gen Physiol Biophys 28, F96-F103.
6. Malhotra JD, &, Kaufman RJ, (2007) The endoplasmic reticulum and the unfolded protein response. Semin Cell Dev Biol 18, 716-731.
7. Burdakov D, Petersen OH, &, Verkhratsky A, (2005) Intraluminal calcium as a primary regulator of endoplasmic reticulum function. Cell Calcium 38, 303-310.
8. Bánhegyi G, Baumeister P, Benedetti A, Dong D, Fu Y, Lee AS, Li J, Mao C, Margittai E, Ni M, et al,. (2007) Endoplasmic reticulum stress. Ann N Y Acad Sci 1113, 58-71.
9. Lai E, Teodoro T, &, Volchuk A, (2007) Endoplasmic reticulum stress: signaling the unfolded protein response. Physiology 22, 193-201.
10. Wuytack F, Raeymaekers L, &, Missiaen L, (2002) Molecular physiology of the SERCA and SPCA pumps. Cell Calcium 32, 279-305.
11. 2+- transport ATPases. Chem Rev 109, 4733-4759.
12. 2+ pumps of the endoplasmic reticulum and Golgi apparatus. Cold Spring Harb Perspect Biol 3, a004184. doi: 10.1101/cshperspect.a004184.
13. 2+-ATPase isoforms are expressed in a cell type? A growing family of membrane proteins illustrated by studies in platelets. Platelets 16, 133-150.
14. Dally S, Corvazier E, Bredoux R, Bobe R, &, Enouf J, (2010) Multiple and diverse coexpression, location, and regulation of additional SERCA2 and SERCA3 isoforms in nonfailing and failing human heart. J Mol Cell Cardiol 48, 633-644.
15. Hovnanian A, (2007) SERCA pumps and human diseases. Subcell Biochem 45, 337-363.
16. Arbabian A, Brouland JP, Gélébart P, Kovács T, Bobe R, Enouf J, &, Papp B, (2011) Endoplasmic reticulum calcium pumps and cancer. BioFactors 37, 139-149.
17. Dellis O, Arbabian A, Brouland JP, Kovács T, Rowe M, Chomienne C, Joab I, &, Papp B, (2009) Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1. Mol Cancer 8, 59.
18. Gélébart P, Kovács T, Brouland JP, van Gorp R, Grossmann J, Rivard N, Panis Y, Martin V, Bredoux R, Enouf J, et al,. (2002) Expression of endomembrane calcium pumps in colon and gastric cancer cells. Induction of SERCA3 expression during differentiation. J Biol Chem 277, 26310-26320.
19. Launay S, Bobe R, Lacabaratz-Porret C, Bredoux R, Kovács T, Enouf J, &, Papp B, (1997) Modulation of endoplasmic reticulum calcium pump expression during T lymphocyte activation. J Biol Chem 272, 10746-10750.
20. Launay S, Giannì M, Kovács T, Bredoux R, Bruel A, Gélébart P, Zassadowski F, Chomienne C, Enouf J, &, Papp B, (1999) Lineage-specific modulation of calcium pump expression during myeloid differentiation. Blood 93, 4395-4405.
21. Papp B, Enyedi A, Kovács T, Sarkadi B, Wuytack F, Thastrup O, Gárdos G, Bredoux R, Lèvy-Toledano S, &, Enouf J, (1991) Demonstration of two forms of calcium pumps by thapsigargin inhibition and radioimmunoblotting in platelet membrane vesicles. J Biol Chem 266, 14593-14596.
22. Papp B, Enyedi A, Pászty K, Kovács T, Sarkadi B, Gárdos G, Magnier C, Wuytack F, &, Enouf J, (1992) Simultaneous presence of two distinct endoplasmic-reticulum-type calcium-pump isoforms in human cells. Characterization by radio-immunoblotting and inhibition by 2,5-di-(t-butyl)-1,4-benzohydroquinone. Biochem J 288, 297-302.
23. 2+ pump is expressed in platelets, in lymphoid cells, and in mast cells. J Biol Chem 269, 1410-1416.
24. 2+-ATPase type 3 gene in endothelial cells is controlled by Ets-1 and Sp1. J Biol Chem 277, 36471-36478.
25. Diederichs F, (2008) Ion homeostasis and the functional roles of SERCA reactions in stimulus-secretion coupling of the pancreatic beta-cell: a mathematical simulation. Biophys Chem 134, 119-143.
26. 2+-ATPase are differentially expressed in normal and diabetic islets of Langerhans. Biochem J 319, 521-527.
27. 2+ ATPase 3 gene. J Biol Chem 279, 24297-24306.
28. 2+-ATPase (SERCA) 1 and 3 isoforms by steady-state and transient kinetic analyses. J Biol Chem 277, 45579-45591.
29. Poch E, Leach S, Snape S, Cacic T, MacLennan DH, &, Lytton J, (1998) Functional characterization of alternatively spliced human SERCA3 transcripts. Am J Physiol 275, C1449-1458.
30. 2+ pumps. Biosci Rep 15, 299-306.
31. Lytton J, Westlin M, Burk SE, Shull GE, &, MacLennan DH, (1992) Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps. J Biol Chem 267, 14483-14489.
32. Chandrasekera PC, Kargacin ME, Deans JP, &, Lytton J, (2009) Determination of apparent calcium affinity for endogenously expressed human sarco(endo)plasmic reticulum calcium-ATPase isoform SERCA3. Am J Physiol Cell Physiol 296, C1105-1114.
33. Lipskaia L, Hulot JS, &, Lompré AM, (2009) Role of sarco/endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation. Pflugers Arch 457, 673-685.
34. Apáti A, Jánossy J, Brõzik A, Bauer PI, &, Magõcsi M, (2003) Calcium induces cell survival and proliferation through the activation of the MAPK pathway in a human hormone-dependent leukemia cell line, TF-1. J Biol Chem 278, 9235-9243.
35. Brini M, &, Carafoli E, (2009) Calcium pumps in health and disease. Physiol Rev 89, 1341-1378.
36. Gill DL, Waldron RT, Rys-Sikora KE, Ufret-Vincenty CA, Graber MN, Favre CJ, &, Alfonso A, (1996) Calcium pools, calcium entry, and cell growth. Biosci Rep 16, 139-157.
37. Sakai A, &, Teshima R, (2001) 2,5-Di-tert-butyl-1,4-hydroquinone enhances cell transformation accompanied by an increase in intracellular free calcium ion concentration. Cancer Lett 168, 183-190.
38. Hakii H, Fujiki H, Suganuma M, Nakayasu M, Tahira T, Sugimura T, Scheuer PJ, &, Christensen SB, (1986) Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanoylphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis. J Cancer Res Clin Oncol 111, 177-181.
39. Prasad V, Okunade GW, Miller ML, &, Shull GE, (2004) Phenotypes of SERCA and PMCA knockout mice. Biochem Biophys Res Commun 322, 1192-1203.
40. Korošec B, Glavac D, Rott T, &, Ravnik-Glavac M, (2006) Alterations in the ATP2A2 gene in correlation with colon and lung cancer. Cancer Genet Cytogenet 171, 105-111.
41. 2+ pumps in association with head and neck squamous cell carcinoma. Cancer Genet Cytogenet 181, 112-118.
42. Korošec B, Glavac D, Volavsek M, &, Ravnik-Glavac M, (2009) ATP2A3 gene is involved in cancer susceptibility. Cancer Genet Cytogenet 188, 88-94.
43. 2+ pump. J Biol Chem 276, 26737-26740.
44. Brouland JP, Gélébart P, Kovács T, Enouf J, Grossmann J, &, Papp B, (2005) The loss of sarco/endoplasmic reticulum calcium transport ATPase 3 expression is an early event during the multistep process of colon carcinogenesis. Am J Pathol 167, 233-242.
45. Papp B, &, Brouland JP, (2011) Altered endoplasmic reticulum calcium pump expression during breast tumorigenesis. Breast Cancer (Auckl) 5, 163-174.
46. Launay S, Giannì M, Diomede L, Machesky LM, Enouf J, &, Papp B, (2003) Enhancement of ATRA-induced cell differentiation by inhibition of calcium accumulation into the endoplasmic reticulum: cross-talk between RAR alpha and calcium-dependent signaling. Blood 101, 3220-3228.
47. Papp B, Brouland JP, Gélébart P, Kovács T, &, Chomienne C, (2004) Endoplasmic reticulum calcium transport ATPase expression during differentiation of colon cancer and leukaemia cells. Biochem Biophys Res Commun 322, 1223-1236.
48. Chang TH, &, Szabõ E, (2000) Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer. Cancer Res 60, 1129-1138.
49. Chang TH, &, Szabõ E, (2002) Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung. Clin Cancer Res 8, 1206-1212.
50. Foster KA, Avery ML, Yazdanian M, &, Audus KL, (2000) Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery. Int J Pharm 208, 1-11.
51. Mathia NR, Timoszyk J, Stetsko PI, Megill JR, Smith RL, &, Wall DA, (2002) Permeability characteristics of calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats. J Drug Target 10, 31-40.
52. - secretion in Calu-3 airway epithelial cells. Am J Physiol 277, L700-708.
53. 2+ probe composed of a single green fluorescent protein. Nat Biotechnol 19, 137-141.
54. Ivics Z, Hackett PB, Plasterk RH, &, Izsvák Z, (1997) Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91, 501-510.
55. Ivics Z, &, Izsvák Z, (2006) Transposons for gene therapy! Curr Gene Ther 6, 593-607.
56. Izsvák Z, &, Ivics Z, (2004) Sleeping beauty transposition: biology and applications for molecular therapy. Mol Ther 9, 147-156.
57. Izsvák Z, Ivics Z, &, Plasterk RH, (2002) Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J Mol Biol 302, 93-102.
58. Alexopoulou AN, Couchman JR, &, Whiteford JR, (2008) The CMV early enhancer/chicken beta actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors. BMC Cell Biol 9, 2.
59. Mates L, Chuah MK, Belay E, Jerchow B, Manoj N, Acosta-Sanchez A, Grzela DP, Schmitt A, Becker K, Mátrai J, et al,. (2009) Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet 41, 753-761.
60. Orbán TI, Apáti A, Németh A, Varga N, Krizsik V, Schamberger A, Szebenyi K, Erdei Z, Várady G, Karàszi E, et al,. (2009) Applying a 'double-feature' promoter to identify cardiomyocytes differentiated from human embryonic stem cells following transposon-based gene delivery. Stem Cells 27, 1077-1087.